American Scientific Resources Signs Letter of Intent to Acquire Intellectual Property
Posted on: Wednesday, 26 August 2009, 13:46 CDT
WESTON, Fla., Aug. 26 /PRNewswire-FirstCall/ -- American Scientific Resources, Inc. (Pink Sheets: ASFX) (the Company), today confirmed that it has signed a letter of intent to acquire the intellectual property to the Disintegrator home needle destruction device (NDD) (U.S. Patent No. 6,384,362 Patent Application No.: 09/500,504).
American Scientific Resources will, upon closing, hold the rights to the patent, a property of Safeguard Medical Technologies. The Company is seeking the rights to the patent as part of ASR's plan to introduce the product commercially in the fall of 2009. Specific terms have not been disclosed pending successful negotiation of the agreement.
Currently the only FDA approved NDD for home use, the Disintegrator enables patients who give themselves injections, including those suffering from multiple sclerosis or diabetes, to properly and safely dispose of needles at home. The device is approved by the EPA and the American Diabetes Association.
Safeguard has already delivered a purchase order for 5000 units to one of the world's leading healthcare enterprises in March of 2009; since then, the global enterprise has placed an additional order for 2000 units which American Scientific Resources will fill. Safeguard practices a form of just-in-time productivity, matching production to its needs based on order size. In order to achieve fulfillment, production is planned to ramp up by year's end with full production capability exceeding 20,000 units per month.
A congressional bill (S, 1312) is pending which would amend Title XVIII of the Social Security Act to provide for coverage, as supplies associated with the injection of insulin, of containment, removal, decontamination, and disposal of home-generated needles, syringes, and other sharps through a sharps decontamination/destruction device or similar program under part D of the Medicare program.
About American Scientific Resources, Inc.
American Scientific Resources, Inc. is a holding company for two wholly owned subsidiaries, Kidz-Med, Inc. and Heart Smart System. The Company's objective is to locate and acquire innovative health and safety products that are successfully sold abroad, and to introduce and promote them to the North American market.
More information about the Company, including financial information, can be found on the ASFX web site at www.americansci.com. For product information, visit the Company's subsidiary, Kidz-Med, Inc. at www.kidzmed.com.
Safe Harbor
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
Contact AudioStocks.com Ronald Garner Investor Hotline: 619-293-0621 ron@bcgu.comSOURCE American Scientific Resources, Inc.
Source: PR Newswire
Related Articles
- Texas American Resources Company Completes New $15 Million Term Loan and Amendment to Its Existing $160 Million Term Loan
- Warrior Girl Corp. and American Resource Petroleum Corp. Sign License Agreement
- Texas American Resources Appoints Drew Pinzur as Vice President of Finance
- Texas American Resources Company Announces Headquarters Relocation
- Texas American Resources Company Announces the Departure of Mike Wichterich as Vice President and Chief Financial Officer
- Texas American Resources Appoints Bryant Williams As Vice President of Engineering
- China Voice Holding Corp. Awarded Exclusive North American Sales Rights For InterEdge Technologies Internet Telephony Products
- American Resource Technologies, Inc. Reports Increased Revenues
- Record Fourth Quarter Sales and Orders Of Viraguard(R) Infection Control Products Projected; Sales and Orders for Q4 Already Exceed $410,000
- NutraCea Signs Agreement With Bi-Coastal Pharmaceutical to Secure Mass Market Distribution for Its Revolutionary Patented Stabilized Rice Bran Products
User Comments (0)

RSS Feeds